A Pharmacy-based Observational Study to Learn More About Iberogast Advance in the Real-world Setting

Clinical trial NCT05389709 · COMPLETED

Trial details

NCT number: NCT05389709
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Functional Gastrointestinal Disorders Such as Irritable Bowel Syndrome and Functional Dyspepsia Irritable Bowel Syndrome Functional Dyspepsia

Start date: 2022-06-04
Primary completion: 2023-05-11
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.